| Document |
Document Title |
|
WO/2024/052739A1 |
A method for the preparation of benzodioxepinone compounds of formula (I), and the intermediates thereof, wherein, R1 is independently selected from the group consisting of hydrogen, halogen, C1-C6 alkyl, C2- C6 alkenyl and C3-C6 cycloal...
|
|
WO/2023/184724A1 |
Disclosed in the present invention are an antimycin compound as well as a preparation method therefor and the use thereof. The compound is characterized in that the compound is separated from a secondary metabolite of marine actinomycete...
|
|
WO/2023/191088A1 |
The present invention provides a polysaccharide which has a degree of polymerisation of 16-40 and is composed only of galactose or composed only of galactose and 1-3 molecules of arabinose, the saccharide units of said polysaccharide bei...
|
|
WO/2023/120250A1 |
Provided is an actinic-ray-sensitive or radiation-sensitive resin composition, etc. that, when forming an ultra-fine pattern (for example, a line and space pattern of 25 nm or less, or a hole pattern with a hole diameter of 25 nm or less...
|
|
WO/2023/010282A1 |
A process to produce a substituted or unsubstituted catechol O, O-diacetic acid ester in a relatively mild condition by reacting a substituted or unsubstituted catechol with a haloacetate in the presence of a base in a first solvent, bef...
|
|
WO/2022/258333A1 |
The invention relates to a process for the manufacture of a cyclic oligo(arylene ether ketone) wherein an aromatic compound such as diphenyl ether is caused to react with terephthaloyl chloride under pseudo-high dilution conditions. The ...
|
|
WO/2022/258332A1 |
The invention relates to a process for the manufacture of a cyclic oligo(arylene ether) which can be a cyclic oligo(dichloromethylene arylene ether) or a cyclic oligo(arylene ether ketone); the process comprises the step of causing an ar...
|
|
WO/2022/172685A1 |
Provided are a method for forming a resist pattern having excellent performance including sensitivity during a light exposure process, LWR performance and CDU performance even when a next-generation light exposure technology is applied t...
|
|
WO/2022/050533A1 |
The present invention provides a novel compound and an organic light-emitting device using same.
|
|
WO/2021/165959A1 |
The present invention provides turn- ON dioxetane-based chemiluminescence probes based on the Schapp's adamantylidene-dioxetane probe, which are useful for determining the presence, or measuring the level, of Mycobacterium tuberculosis (...
|
|
WO/2021/086977A1 |
Described herein are 1,2-dioxetanes that are useful as chemiluminescent probes, diagnostic agents, and imaging agents. Also described herein are compositions containing such compounds and methods of using the same.
|
|
WO/2021/049592A1 |
Provided are a radiation-sensitive resin composition with which it is possible to form a resist pattern having excellent sensitivity to exposure light and having exceptional LWR performance and resolution, a resist pattern formation meth...
|
|
WO/2021/041320A1 |
Provided are novel prodrugs of treprostinil, as well as methods of making and methods of using these prodrugs.
|
|
WO/2021/034173A1 |
The present invention relates to a novel derivative of lobaric acid, a preparation method therefor and a use thereof, and relates to: a novel lobaric acid derivative which has excellent PTP-1B inhibitory activity that is far higher than ...
|
|
WO/2021/020114A1 |
The present invention addresses the problem of providing a compound having an excellent change rate of HTP due to exposure. In addition, the present invention addresses another problem of providing a liquid crystal composition, a cured p...
|
|
WO/2020/243540A1 |
Disclosed are cationic lipids which are compounds of Formula I. Cationic lipids provided herein can be useful for delivery and expression of mRNA and encoded protein, e.g., as a component of liposomal delivery vehicle, and accordingly ca...
|
|
WO/2020/209035A1 |
A compound represented by formula (1). R1 is, for example, an alkyl having 1-15 carbon atoms; ring A1 and ring A2 are 1,4-phenylene, etc.; a is 2, etc.; b and c are 0, 1, or 2; Z1 is a single bond, etc.; P1 and P2 are polymerizable group...
|
|
WO/2020/189464A1 |
The purpose of the present invention is to provide a cyclic poly(arylene ether ketone) composition having high fluidity when heated and melted. The cyclic poly(arylene ether ketone) composition according to the present invention contai...
|
|
WO/2020/175185A1 |
The present invention addresses the problem of providing a compound which has an excellent rate of HTP change due to exposure to light. Also, the present invention addresses another problem of providing a composition, a cured product, an...
|
|
WO/2020/124433A1 |
Provided herein is a process for preparing acetals or ketals by reacting Alcohol I, Alcohol II and oxygen in the presence of a metal-organic framework (MOF) catalyst.
|
|
WO/2020/092383A1 |
The present disclosure provides a compound of Formula (I): or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processe...
|
|
WO/2020/050322A1 |
The present invention addresses the problem of providing: a compound which increases in HTP upon exposure to light by irradiation with, for example, ultraviolet light; and a mixture containing the compound. The present invention further ...
|
|
WO/2020/049957A1 |
The present invention provides a compound having an excellent rate of HTP change by exposure to light. In addition, the present invention provides a composition, a cured product, an optically anisotropic body, and a reflective film, whic...
|
|
WO/2020/008052A1 |
The present invention relates to a compound of the following formula (I): (I). The invention also relates to uses thereof as dye or pigment, notably as a luster pigment. The invention relates also to a reflective or photonic or nanophoto...
|
|
WO/2020/008051A1 |
The present invention relates to a compound of the following formula (I): (I). The invention also relates to uses thereof as dye or pigment, notably as a luster pigment,and to areflective or photonic or nanophotonic or optoelectronic dev...
|
|
WO/2019/224339A1 |
The present invention relates to dioxetane compounds of Formula la or lb, a compound of Formula II and their applications.
|
|
WO/2019/224338A1 |
The present invention relates to dioxetane compounds, their use in the detection of presence or absence, quantification and identification of microorganisms including bacteria, bacterial fragments (e.g., LPS, endotoxin), viruses, fungi a...
|
|
WO/2019/205147A1 |
The present invention relates to an amino acetamide compound containing a benzo oxygen-containing aliphatic ring structure and a use thereof. In particular, disclosed are a compound represented by formula I or a pharmaceutically acceptab...
|
|
WO/2019/181433A1 |
The present invention provides a compound showing a large change in HTP upon light exposure. The present invention further provides a composition including the compound, a cured object, an optically anisotropic object, and a reflective f...
|
|
WO/2019/165890A1 |
Provided herein are chiral compounds that exhibit circularly polarized photoluminescence and electroluminescence and electroluminescent devices and circularly polarized fluorescent probes comprising the same.
|
|
WO/2019/088270A1 |
The present invention provides a compound that is highly safe and that is useful in the prevention, alleviation, and/or treatment of various diseases involving enteropeptidase inhibition and/or trypsin inhibition, a pharmaceutical compos...
|
|
WO/2019/067543A1 |
The present disclosure relates to compounds that are capable penetrating to the blood brain barrier to modulate the activity of EGFR tyrosine kinase. The disclosure further relates to methods of treating Glioblastoma and other EGFR media...
|
|
WO/2018/216012A1 |
The present invention provides turn-ON dioxetane-based chemiluminescence probes based on the Schapp's adamantylidene-dioxetane probe, which are capable of detecting or imaging, more specifically, determining the presence, or measuring th...
|
|
WO/2018/122359A1 |
The present invention relates to a compound of the following formula (I). The invention also relates to uses thereof as a chromophore as such or for building pigments displaying special optical effects, including metal-like reflection.
|
|
WO/2018/100515A1 |
The invention relates to novel ruthenium complexes of formula (9). The invention also relates to the method for preparation of novel metal complexes of formula (9) and their use in olefin metathesis reactions.
|
|
WO/2018/006031A1 |
The invention provides methods for the synthesis of a halichondrin macrolides or analogs thereof through a cyclization reaction strategy. The strategy of the present invention involves subjecting an intermediate to Prins reaction conditi...
|
|
WO/2017/192304A1 |
The present disclosure is directed to compounds of formula (I): or a pharmaceutically acceptable salt, solvate or solvate of the salt thereof. Compounds of formula (I) are inhibitors of NOX4 and are useful in the treatment of fibrotic di...
|
|
WO/2017/191282A1 |
The present invention regards new adipate-type compounds suitable as an intermediate in organic chemistry, a platform chemical for the production of other chemicals, and as a monomer and co-monomer useful for the preparation of polymers ...
|
|
WO/2017/177026A1 |
In alternative embodiments, provided are methods for: modifying circadian rhythmicity or timing in a mammal, treating psychiatric conditions or symptoms due to alterations in a human circadian regulatory system, treating sleep problems i...
|
|
WO/2017/177004A1 |
Compunds of Formula (I) and pharmaceutically acceptable salts thereof, wherein G1, G2, G3, L1, L2, and L3 are as defined in the specification, are useful in treating conditions or disorders prevented by or ameliorated by the modulation o...
|
|
WO/2017/173105A1 |
Reagents for stabilizing the nucleic acids of a biological cell, compositions, kits and methods of use thereof are described. The stabilization reagents may prepare the nucleic acids within the biological cell for storage and preserve th...
|
|
WO/2017/158404A1 |
This invention relates to an improved method for preparing alkylenedioxybenzene compounds of Formula I, from the corresponding ortho-dihydroxy aromatic compound of Formula II wherein n is 0, 1, 2 or 3; and R1 and R2 independently represe...
|
|
WO/2017/148874A1 |
The invention refers to a modular continuous flow device for automated chemical multistep synthesis under continuous flow conditions. The device comprises a plurality of different types of continuous flow modules and a valve assembly for...
|
|
WO/2017/130191A1 |
The present invention provides dioxetane-based chemiluminescence probes, more specifically fluorophore-tethered dioxetane-based chemiluminescence probes and π* acceptor group-containing dioxetane based chemiluminescence probes, and com...
|
|
WO/2017/116949A1 |
This disclosure relates to macrocyclic picolinamides of Formula (I) and their use as fungicides.
|
|
WO/2017/096559A1 |
The present invention relates to the production of xylene derivatives from furfural and its derivatives. The invention describes new routes for converting furfural and its derivatives into xylene derivatives including novel intermediates.
|
|
WO/2017/003188A1 |
The present invention relates to: a novel compound which has an outstanding luminescent ability; and an organic electroluminescent element having improved properties including high luminous efficiency, low drive voltage and long lifespan...
|
|
WO/2016/201214A1 |
The present invention relates to compounds which have been discovered to be potent ligands (inhibitors) of human GLUT5 (glucose transporter type 5), a facilitative glucose transporter that transports fructose, and their use as ligands as...
|
|
WO/2016/104630A1 |
The present invention pertains to: a condensed heterocyclic compound having an inhibitory effect on enteropeptidase, the condensed heterocyclic compound being useful in the treatment or prevention of obesity, diabetes, and the like; and ...
|
|
WO/2016/097569A1 |
The invention relates to novel fragrant compounds having animalic or ambergris notes, without any woody characteristic. More specifically, the invention relates to novel acetal derivatives of 1-(3,3-dimethylcyclohex-1-enyl) ethanone of g...
|
